Anondita Medicare Board of Directors

Get the latest insights into the leadership at Anondita Medicare. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Anupam Ghosh Managing Director
Mrs. Sonia Ghosh Whole Time Director
Mr. Reshant Ghosh Whole Time Director
Ms. Nishi Goel Independent Director
Mr. Gaurav Kumar Independent Director
Mr. Lakhinder Singh Non Independent Director

Anondita Medicare Share price

ANONDITA

334.75

15.90 (4.99%)
NSE
BSE
Last updated on 4 Sep, 2025 | 14:20 IST
BUYSELL
Today's High

334.75

Today's Low

320.00

52 Week Low

261.75

52 Week High

334.75

The current prices are delayed, login to your account for live prices

Anondita Medicare FAQs

The board at Anondita Medicare consists of experienced professionals, including Mr. Anupam Ghosh , Mrs. Sonia Ghosh , and others, overseeing the company’s strategic and corporate governance.

Directors at Anondita Medicare are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Anupam Ghosh is the current chairman at Anondita Medicare.

Executive directors at Anondita Medicare are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Anondita Medicare adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Anondita Medicare, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.